Stroke attributable to acute basilar occlusion

Current Treatment Options in Neurology

Volumn 9, Issue 2, 2007, Pages 126-135

  Bergui, Mauro ^a   Cerrato, Paolo ^b   Bradac, Gianni Boris ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; UROKINASE;

ARTERY CATHETERIZATION; ASPIRATION; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HUMAN; NEUROIMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROGNOSIS; RECANALIZATION; REVIEW; STENT; TIME MANAGEMENT; TREATMENT OUTCOME; VERTEBROBASILAR INSUFFICIENCY;

EID: 33847643746     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-007-0038-x     Document Type: Review

References (54)

1. Duvernoy H: Human Brain Stem Vessels. Berlin: Springer; 1999.
2. Foix C, Hillemand P: Les arteres de l'axe encephalique jusq'au diencephale inclusivement. Rev Neurol 1925, 2:705-739.
3. Chaturvedi S, Lukovits TG, Chen W, Gorelick PB: Ischemia in the territory of a hypoplastic vertebrobasilar system. Neurology 1999, 52:980-983.
4. Leyden E: Ueber die Thrombose der Basilar-Arterie. Z Clin Med 1882, 5:165-185.
5. Kubik CS, Adams RD: Occlusion of the basilar artery: a clinical and pathological study. Brain 1946, 69:73-121.
6. Haugstep H: Occlusion of the basilar artery: diagnosis by vertebral angiography during life. Neurology 1956, 6:823-828.
7. von Campe G, Regli F, Bogousslavsky J: Heralding manifestations of basilar artery occlusion with lethal or severe stroke. J Neurol Neurosurg Psychiatry 2003, 74:1621-1626.
8. Fields WS, Ratinov G, Weibel J, Campos RJ: Survival following basilar artery occlusion. Arch Neurol 1966, 15:463-471.
9. Fisher CM: Occlusion of the vertebral arteries. Causing transient basilar symptoms. Arch Neurol 1970, 22:13-19.
10. Caplan LR: Occlusion of the vertebral or basilar artery: follow up analysis of some patients with benign outcome. Stroke 1979, 10:277-282.
11. Pessin MS, Caplan LR: Heterogeneity of vertebrobasilar occlusive disease. In Clinical Problems of Brainstem Disorders. Edited by Kunze K, Zangemeister M. New York: Thieme Verlag; 1986:30-42.
12. Schonewille WJ, Michel P, Wijman CA, et al.: The Basilar Artery International Cooperation Study (BASICS) progress report. Basics Study. Presented at the European Stroke Conference. Brussels, Belgium. May 16-19, 2006.
13. Arakawa S, Wright PM, Koga M, et al.: Ischemic thresholds for gray and white matter: a diffusion and perfusion magnetic resonance study. Stroke 2006, 37:1211-1216.
14. Steinke W, Ley SC: Lacunar stroke is the major cause of progressive motor deficits. Stroke 2002, 33:1510-1516.
15. Ferbert A, Buchner H, Bruckmann H, et al.: Evoked potentials in basilar artery thrombosis: correlation with clinical and angiographic findings. Electroencephalogr Clin Neurophysiol 1988, 69:136-147.
16. Ringelstein EB, Zeumer H, Poeck K: Non-invasive diagnosis of intracranial lesions in the vertebrobasilar system. A comparison of Doppler sonographic and angiographic findings. Stroke 1985, 16:848-855.
17. Baird TA, Muir KW, Bone I: Basilar artery occlusion. Neurocrit Care 2004, 1:319-329.
18. Davis SM, Donnan GA: Basilar artery thrombosis: recanalization is the key. Stroke 2006, 37:2440.
19. Hacke W, Zeumer H, Ferbert A, et al.: Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988, 19:1216-1222.
20. Devuyst G, Bogousslavsky J, Meuli R, et al.: Stroke or transient ischemic attacks with basilar artery stenosis or occlusion. Arch Neurol 2002, 59:567-573.
21. Lindsberg PJ, Soinne L, Roine RO, Tatlisumak T: Options for recanalization therapy in basilar artery occlusion. Stroke 2005, 36:203-204.
22. Brandt T, von Kummer R, Mueller-Kuppers M, Hacke W: Thrombolytic therapy of acute basilar artery occlusion: variables affecting recanalization and outcome. Stroke 1996, 27:875-881.
23. Cross DT III, Moran CJ, Akins PT, et al.: Collateral circulation and outcome after basilar artery thrombolysis. Am J Neuroradiol 1998, 19:1557-1563.
24. Voetsch B, DeWitt LD, Pessin MS, Caplan LR: Basilar artery occlusive disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol 2004, 61:496-504.
25. Hacke W, Kaste M, Fieschi C, et al.: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998, 352:1245-1251.
26. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995, 333:1581-1587.
27. Schonewille WJ, Algra A, Serena J, et al.: Outcome in patients with basilar artery occlusion treated conventionally. J Neurol Neurosurg Psychiatry 2005, 76:1238-1241.
28. Moscow NP, Newton TH: Angiographic implications in diagnosis and prognosis of basilar artery occlusion. Am J Roentgenol Radium Ther Nucl Med 1973, 119:597-604.
29. Bruckmann H, Ferbert A, del Zoppo GJ, et al.: Acute vertebral-basilar thrombosis. Angiologic-clinical comparison and therapeutic implications. Acta Radiol Suppl 1986, 369:38-42.
30. Ostrem JL, Saver JL, Alger JR, et al.: Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies. Stroke 2004, 35:30-34.
31. Prosser J, Butcher K, Allport L, et al.: Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 2005, 36:1700-1704.
32. Hennerici M, Hacke W, von Kummer R, et al.: Intravenous tissue plasminogen activator for the treatment of acute thromboembolic ischemia. Cerebrovasc Dis 1991, 1(Suppl 1):124-128.
33. Huemer M, Niederwieser V, Ladurner G: Thrombolytic treatment for acute occlusion of the basilar artery. J Neurol Neurosurg Psychiatry 1995, 58:227-228.
34. Lindsberg PJ, Soinne L, Tatlisumak T, et al.: Long-term outcome after intravenous thrombolysis of basilar artery occlusion. JAMA 2004, 292:1862-1866.
35. Furlan A, Higashida R, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282:2003-2011.
36. Zeumer H, Hacke W, Ringelstein EB: Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. Am J Neuroradiol 1983, 4:401-404.
37. Del Zoppo GJ, Zeumer H, Harker LA: Thrombolytic therapy in stroke: possibilities and hazards. Stroke 1986, 17:595-607.
38. Macleod MR, Davis SM, Mitchell PJ, et al.: Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis 2005, 20:12-17.
39. Brandt T, von Kummer R, Muller-Kuppers M, et al.: Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996, 27:875-881.
40. Becker KJ, Monsein LH, Ulatowski J, et al.: Intraarterial thrombolysis in vertebrobasilar occlusion. AJNR Am J Neuroradiol 1996, 17:255-262.
41. Levy EI, Firlik AD, Wisniewski S, et al.: Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intraarterial thrombolytic therapy: a meta-analytical approach. Neurosurgery 1999, 45:539-545.
42. Berg-Dammer E, Felber SR, Henkes H, et al.: Long-term outcome after local intra-arterial fibrinolysis of basilar artery thrombosis. Cerebrovasc Dis 2000, 10:183-188.
43. Sliwka U, Mull M, Syelzer A, et al.: Long-term follow-up of patients after intraarterial thrombolytic therapy of acute vertebrobasilar artery occlusion. Cerebrovasc Dis 2001, 12:214-219.
44. Eckert B, Kucinski T, Pfeiffer G, et al.: Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor. Cerebrovasc Dis 2002, 14:42-50.
45. Ezaki Y, Tsutsumi K, Onizuka M, et al.: Retrospective analysis of neurological outcome after intra-arterial thrombolysis in basilar artery occlusion. Surg Neurol 2003, 60:423-430.
46. Arnold M, Nedeltchev K, Schroth G, et al.: Clinical and radiological predictors of recanalization and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004, 75:857-862.
47. Eckert B, Koch C, Thomalla G, et al.: Aggressive therapy with intravenous abciximab and intraarterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study. Stroke 2005, 36:1160-1165.
48. Qureshi AI, Boulos AS, Hanel RA, et al.: Randomized comparison of intra-arterial and intravenous thrombolysis in a canine model of acute basilar artery thrombosis. Neuroradiology 2004, 46:988-995.
49. Smith WS, Sung G, Starkman S, et al.: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005, 36:1432-1438.
50. Mayer TE, Hamann GF, Brueckmann HJ: Treatment of basilar artery embolism with a mechanical extraction device: necessity of flow reversal. Stroke 2002, 33:2232-2235.
51. Nedeltchev K, Remonda L, Do DD, et al.: Acute stenting and thromboaspiration in basilar artery occlusions due to embolism from the dominating vertebral artery. Neuroradiology 2004, 46:686-691.
52. Mayer TE, Hamann GF, Schulte-Altedorneburg G, Brückmann H: Treatment of vertebrobasilar occlusion by using a coronary waterjet thrombectomy device: a pilot study. AJNR Am J Neuroradiol 2005, 26:1389-1394.
53. Favrole P, Saint-Maurice JP, Bousser MG, Houdart E: Use of mechanical extraction devices in basilar artery occlusion. J Neurol Neurosurg Psychiatry 2005, 76:1462-1464.
54. Bergui M, Stura G, Daniele D, et al.: Mechanical thrombolysis in ischemic stroke attributable to basilar artery occlusion as first-line treatment. Stroke 2006, 37:145-150.